The relation of amino-terminal propeptide of type III procollagen and severity of coronary artery disease in patients without myocardial infarction or hibernation

Clinical Biochemistry

Volumn 39, Issue 9, 2006, Pages 861-866

  Lin, Yen Hung ^a   Ho, Yi Lwun ^a,b   Wang, Tzung Dau ^a   Liu, Chung Pin ^a,c   Kao, Hsien Li ^a   Chao, Chia Lun ^a   Chien, Kuo Liong ^a   Hung, Chi Sheng ^a   Wu, Vin Cent ^a   Tsai, I Jung ^a   Yen, Ruoh Fang ^a   Shiau, Yu Chien ^b   Chen, Wen Jone ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c YUAN'S GENERAL HOSPITAL   (Taiwan)

Author keywords

Coronary artery disease; Myocardial fibrosis; PIIINP; PINP

Indexed keywords

DIPYRIDAMOLE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; THALLIUM 201;

ADULT; AGED; APPARATUS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE FIBROSIS; HIBERNATION; HUMAN; HYPERTENSION; IMAGE ANALYSIS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS; THORAX PAIN;

AGED; BIOLOGICAL MARKERS; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY VESSELS; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PEPTIDE FRAGMENTS; PROCOLLAGEN; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33748435020     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.05.017     Document Type: Article

References (28)

1. Heeneman S., Cleutjens J.P., Faber B.C., et al. The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis. J. Pathol. 200 (2003) 516-525
2. Lopez B., Gonzalez A., Varo N., Laviades C., Querejeta R., and Diez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 38 (2001) 1222-1226
3. Lombardi R., Betocchi S., Losi A., et al. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 108 (2003) 1455-1460
4. Uusimaa P., Risteli J., Niemela M., et al. Collagen scar formation after acute myocardial infarction relationship to infarct size, ventricular function, and coronary artery patency. Circulation 96 (1997) 2565-2572
5. Cicoira M., Rossi A., Bonapace S., et al. Independent and additional prognostic value of amino-terminal propeptide of type III procollagen circulating levels in patients with chronic heart failure. J. Card. Fail. 10 (2004) 403-411
6. Zannad F., Alla F., Dousset B., Perez A., and Pitt B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spirolactone therapy in patients with congestive heart failure. Circulation 102 (2000) 2700-2706
7. Sutton M.G.S.J., and Sharpe N. Left ventricular remodeling after myocardial infarction pathophysiology and therapy. Circulation 101 (2000) 2981-2988
8. Poulsen S.H., Host N.B., and Jensen S.E. Relationship between serum amino-terminal propeptide of type III procollagen and change of left ventricular function after acute myocardial infarction. Circulation 102 (2000) 1527-1532
9. Tsuda T., Gao E., Evangelisti L., Markova D., Ma X., and Chu M. Post-ischemic myocardial fibrosis occurs independent of hemodynamic changes. Cardiovasc. Res. 59 (2003) 926-933
10. Elsasser A., Vogt A.M., Nef H., et al. Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death. J. Am. Coll. Cardiol. 43 (2004) 2191-2199
11. Diez J., Laviades C., Mayor G., Gil M.J., and Monreal I. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation 91 (1995) 1450-1456
12. Melkko J., Kauppila S., Niemi S., Risteli L., Haukipuro K., Jukkola A., et al. Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin. Chem. 42 (1996) 947-954
13. Risteli J., Niemi S., Trivedi P., Mäentausta O., Mowat A.P., and Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin. Chem. 34 (1988) 715-718
14. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendation regarding quantitation in M-mode echocardiography: results of survey of echocardiographic measurements. Circulation 58 (1987) 1072-1083
15. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-dimensional Echocardiograms. J. Am. Soc. Echocardiogr. 2 (1989) 358-367
16. Devereux R.B., and Reichek N. Echocardiographic determination of left ventricular mass in man: anatomical validation of the method. Circulation 55 (1977) 613-618
17. Iskandian A.S., Heo J., Askenase A., Segal B.L., and Helfant R.H. Thallium imaging with single photon emission computed tomography. Am. Heart J. 114 (1987) 852-865
18. Huang P.J., Yen R.F., Chieng P.U., Chen M.L., and Su C.T. Do beta-blockers affect the diagnostic sensitivity of dobutamine stress thallium-201 single photon emission computed tomographic imaging?. J. Nucl. Cardiol. 5 (1998) 34-39
19. Ho Y.L., Chen C.L., Hsu R.B., et al. Assessment of the myocardial changes in heart transplant recipients without evident acute myocardial rejection by integrated backscatter: comparison with simultaneous dobutamine stress echocardiography and Thallium-201 SPECT. Ultrasound Med. Biol. 27 (2001) 171-179
20. Host N.B., Aldershvile J., Horslev-Petersen K., Hoyer S., and Haunso S. Serum aminoterminal propeptide of type III procollagen after cardiac transplantation and the effect of rejection. Am. J. Cardiol. 78 (1996) 1406-1410
21. Lin Y.H., Shiau Y.C., Yen R.F., et al. The relation between myocardial cyclic variation of integrated backscatter and serum concentrations of procollagen propeptides in hypertensive patients. Ultrasound Med. Biol. 30 (2004) 885-891
22. Bishop J.E., and Laurent G.J. Collagen turn-over and its regulation in the normal and hypertrophing heart. Eur. Heart J. 16 (1995) 38-44
23. Alla F., Kearney-Schwartz A., Radauceanu A., Dores S.D., Dousset B., and Zannad F. Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes. Eur. J. Heart Fail. 8 (2006) 147-153
24. Bonnet J., Garderes P.E., Aumailley M., et al. Serum type III procollagen peptide levels in coronary artery disease (a marker of atherosclerosis). Eur. J. Clin. Invest. 18 (1988) 18-21
25. Wasywich C.A., Webster M.W.I., Richards A.M., and Stewart R.A.H. Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with Coronary heart disease. Am. J. Cardiol. 97 (2006) 1068-1072
26. Bishop J.E., and Lindahl G. Regulation of cardiovascular collagen synthesis by mechanical load. Cardiovasc. Res. 42 (1999) 27-44
27. Diez J., Lopez B., Gonzalez A., and Querejeta R. Clinical aspects of hypertensive myocardial fibrosis. Curr. Opin. Cardiol. 16 (2001) 328-335
28. Lopez B., Gonzalez A., Varo N., Laviades C., Querejeta R., and Diez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 38 (2001) 1222-1226